CAI Q3 2016 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q3 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$78M+18.7% YoY

Gross Profit

$31M38.9% margin

Operating Income

$11M13.6% margin

Net Income

-$5M-6.9% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+9.5%

Cash Flow

Operating Cash Flow

$33M

Free Cash Flow

-$7M

Stock-Based Comp.

$412,000

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.6B

Stockholders' Equity

$459M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$78M	$66M	+18.7%
Gross Profit	$31M	$39M	-20.9%
Operating Income	$11M	$23M	-53.9%
Net Income	-$5M	$13M	-141.7%